EUVIMEDEUVIMED entdecken
Crossref

A Bayesian Model with Application for Adaptive Platform Trials Having Temporal Changes

Chenguang Wang iD, Min Lin, Gary L Rosner, Guoxing Soon

Biometrics · 01.06.2023 · 79 (2) · 1446-1458

DOI: 10.1111/biom.13680 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biometrics, online erschienen am 27.04.2022. Verfasst von Chenguang Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Research Design, Algorithms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Temporal changes exist in clinical trials. Over time, shifts in patients' characteristics, trial conduct, and other features of a clinical trial may occur. In typical randomized clinical trials, temporal effects, that is, the impact of temporal changes on clinical outcomes and study analysis, are largely mitigated by randomization and usually need not be explicitly addressed. However, temporal effects can be a serious obstacle for conducting clinical trials with complex designs, including the adaptive platform trials that are gaining popularity in recent medical product development. In this paper, we introduce a Bayesian robust prior for mitigating temporal effects based on a hidden Markov model, and propose a particle filtering algorithm for computation. We conduct simulation studies to evaluate the performance of the proposed method and provide illustration examples based on trials of Ebola virus disease therapeutics and hemostat in vascular surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Research DesignAlgorithmsHumansBayes TheoremSample SizeComputer SimulationAdaptive Clinical Trials as Topic

Stichwörter der Autor:innen

adaptive platform trialclinical trial designcomplex innovative designtemporal changetemporal effect-adjusted prior

Autor:innen und Institutionen

  • Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland, USA.
  • BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.

ORCID-Profile: Chenguang Wang

Förderung

  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Wang, C., Lin, M., Rosner, G. L., & Soon, G. (2023). A Bayesian Model with Application for Adaptive Platform Trials Having Temporal Changes. Biometrics, 79(2), 1446-1458. https://doi.org/10.1111/biom.13680

Vancouver

Wang C, Lin M, Rosner GL, Soon G. A Bayesian Model with Application for Adaptive Platform Trials Having Temporal Changes. Biometrics. 2023;79(2):1446-1458. doi:10.1111/biom.13680

BibTeX
@article{Wang2023,
  author = {Wang, Chenguang and Lin, Min and Rosner, Gary L and Soon, Guoxing},
  title = {A Bayesian Model with Application for Adaptive Platform Trials Having Temporal Changes},
  journal = {Biometrics},
  year = {2023},
  volume = {79},
  number = {2},
  pages = {1446--1458},
  doi = {10.1111/biom.13680}
}
Kostenlos starten →